Adipose-derived stem cell exosomes for treatment of dupilumab-related facial redness in patients with atopic dermatitis
Background Dupilumab facial redness (DFR) is a side effect of dupilumab treatment that has only been recently reported. We previously reported on two patients with DFR who were successfully treated with a topical formulation containing human adipose tissue-derived mesenchymal stem cell-derived exoso...
Saved in:
Main Authors: | Hye Sung Han (Author), Young Gue Koh (Author), Jun Ki Hong (Author), Yoon Jin Roh (Author), Seong Jun Seo (Author), Kui Young Park (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab
by: Sean J. Igelman, BS, et al.
Published: (2020) -
443 Dupilumab for Children and Adolescents with Atopic Dermatitis: An Asian Perspective
by: Shi Yun Chia, et al.
Published: (2021) -
Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023) -
Efficacy of dupilumab in moderate and severe atopic dermatitis
by: Stephan Weidinger, et al.
Published: (2023) -
Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
by: Shan J, et al.
Published: (2022)